Antimicrobial therapies developed from immunology, specifically the primary function of the immune system in host defence against microbial pathogens, could offer some of the step-change strategies in drug design and development urgently required to generate much needed, truly novel interventions in infectious disease. The immune system is an as yet underexploited resource of novel molecules and the blueprints for new approaches to combating infection with non-antibiotic, directly antimicrobial strategies.
Keywords: Aminothiol; Antimicrobial peptide; Antimicrobial resistance; Antimicrobial therapy; Immunotherapy.
Copyright © 2021 Elsevier Ltd. All rights reserved.